Trial Profile
An Italian observational, multicenter, retrospective study of lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 06 May 2016 New trial record